MIU
CRL icon

Man Investments (UK)’s Charles River Laboratories CRL Stock Holding History

Man Investments (UK)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-33,153
Closed -$1.53M – 627
2013
Q3 		$1.53M Buy
33,153
+26,935
+433% +$1.24M 0.21% 180
2013
Q2 		$255K Buy
+6,218
New +$266K 0.06% 327

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Man Investments (UK)'s CRL Position: Q4 2013 in Review

Man Investments (UK) sold out of Charles River Laboratories (CRL) in Q4 2013, closing a stake of 33,153 shares — an estimated $1.53M sold.

Man Investments (UK) first reported a position in CRL in Q2 2013 and held it in 2 quarters. The position peaked at $1.53M in Q3 2013. 239 funds tracked by Wall St. Rank hold CRL as of Q4 2013.

  • Man Investments (UK) reported no remaining Charles River Laboratories position as of Q4 2013 after selling out during the quarter.
  • Man Investments (UK) sold 33,153 Charles River Laboratories shares in Q4 2013, an estimated $1.53M.
  • Man Investments (UK) first reported a position in Charles River Laboratories in Q2 2013 and held it in 2 quarters.
  • Man Investments (UK)'s Charles River Laboratories position peaked at $1.53M in Q3 2013.
  • 239 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2013.

Based on Man Investments (UK)'s 13F filing for Q4 2013, filed 14 Feb 2014.